Microbix Biosystems Inc. (TSX: MBX)

Market Cap	45.06M
Revenue (ttm)	23.84M
Net Income (ttm)	4.06M
Shares Out	137.42M
EPS (ttm)	0.03
PE Ratio	11.00
Forward PE	17.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	52,100
Open	0.345
Previous Close	0.350
Day's Range	0.330 - 0.345
52-Week Range	0.230 - 0.450
Beta	0.25
Analysts	n/a
Price Target	0.80 (+142.42%)
Earnings Date	Aug 8, 2024

About Microbix Biosystems

Microbix Biosystems Inc., a life science company, develops and commercializes proprietary biological and technological solutions for human health and wellbeing in North America, Europe, and internationally. The company manufactures diagnostic-test products, such as test-controls under the QAPs brand; viral transport medium for collection of patient samples to test for pathogens including virus causing the COVID-19 disease under the DxTM brand; Kinlytic, a biologic thrombolytic drug used to treat blood clots; and antigen products. Microbix Biosy...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1988
• Country: Canada
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: MBX